Adam Havey's most recent trade in Emergent Biosolutions Inc was a trade of 49,231 Employee Stock Option (Right to buy) done . Disclosure was reported to the exchange on June 9, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 49,231 | 161,906 | - | - | Employee Stock Option (Right to buy) | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 49,231 | 174,398 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 24,616 | 125,167 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 12,308 | 100,551 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 12,308 | 112,675 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 6,154 | 88,243 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.38 per share. | 28 Feb 2023 | 998 | 33,927 (0%) | 0% | 12.4 | 12,355 | Common Stock |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.71 per share. | 23 Feb 2023 | 812 | 33,681 (0%) | 0% | 13.7 | 11,133 | Common Stock |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.30 per share. | 23 Feb 2023 | 432 | 34,493 (0%) | 0% | 14.3 | 6,178 | Common Stock |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.25 per share. | 08 Feb 2023 | 1,964 | 34,925 (0%) | 0% | 13.3 | 26,023 | Common Stock |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 95 | 36,889 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 42,289 | 42,289 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,323 | 69,117 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 17,822 | 86,939 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.64 per share. | 28 Feb 2022 | 739 | 86,200 (0%) | 0% | 39.6 | 29,294 | Common Stock |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 23 Feb 2022 | 828 | 36,794 (0%) | 0% | 42.5 | 35,165 | Common Stock |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.23 per share. | 23 Feb 2022 | 424 | 37,622 (0%) | 0% | 42.2 | 17,906 | Common Stock |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.23 per share. | 22 Feb 2022 | 1,980 | 38,046 (0%) | 0% | 42.2 | 83,615 | Common Stock |
| Emergent Biosolutions Inc | Adam Havey | EVP, Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 1,836 | 40,026 (0%) | 0% | 0 | Common Stock |